At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 50 enrolled
Drug / intervention
Carbetocindrug
Likely dose
Carbetocin 50 mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Carbetocin Dose on Dispersion of Myocardial Repolarization in Healthy Parturients Scheduled for Elective Cesarean Delivery Under Spinal Anesthesia
In Brief
A Phase 4 clinical trial evaluating Carbetocin for Cardiac Arrythmias. Completed, enrolled 50 participants across 1 site.
Detailed Summary
Relationship between carbetocin dose on transmural dispersion of repolarization (TDR).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrythmias
CountriesCanada
Collaborators--
Timeline
Phase 4CompletedFinished
20192020202120222023202420252026
First PostedOct 2018
Enrollment StartNov 2018
Primary CompletionJun 2019
Study CompletionApr 2020
TodayJul 2026
First PostedOct 23, 2018
Enrollment StartNov 1, 2018
Primary CompletionJun 15, 2019
Study CompletionApr 24, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.7 years ago
Interventions
Carbetocindrug
50 mcg or 100 mcg bolus of carbetocin